Presentation platform
for clinical trials
On this page, current and planned clinical studies are presented by scientists of the Charité, who would like to present them on the Internet.
If you are interested in participating in one of the presented clinical studies, you can contact the corresponding clinic. The clinic will be displayed on the detail page after selecting the study.
You are here:
Filter results
NeuroMET2 - Metrologie und Innovation zur Früherkennung und genauen Stratifizierung von Patienten mit neurodegenerativen Erkrankungen
Short title: NeuroMET2
Investigated disease: AD
Principal Investigator: Laura Göschel
Patient (diseased)
Status: Participants wanted
PROSA
Short title: PROSA-Register
Investigated disease: acute symptomatic seizures
Principal Investigator: Prof. Dr. Martin Holtkamp
Patient (diseased)
Age: 18 - 199
Gender: All
Status: Participants wanted
Title: The AIM-HN and SEQ-HN Study: A 2 Cohort, Non-comparative, Pivotal Study Evaluating the Efficacy of Tipifarnib in Patients with Head and Neck Squamous Cell Carcinoma (HNSCC) with HRAS Mutations (AIM-HN) and the Impact of HRAS Mutations on Response to First Line Systemic Therapies for HNSCC (SEQ-HN).
Short title: Kura KO-TIP 007
Investigated disease: hnscc
Principal Investigator: PD Dr. med. Konrad Klinghammer
Patient (diseased)
RIBANNA
Short title: RIBANNA
Investigated disease: Metastasiertes Hormonrezeptor positives Mammakarzinom
Principal Investigator: Verena Kiver
Patient (diseased)
Age: 18 - 99
Gender: Female
Status: Participants wanted
PHASE III, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER STUDY TO EVALUATE THE EFFICACY AND SAFETY OF ETROLIZUMAB AS AN INDUCTION AND MAINTENANCE TREATMENT FOR PATIENTS WITH MODERATELY TO SEVERELY ACTIVE CROHN'S DISEASE
Short title: GA29144 Bergamot
Investigated disease: Morbus Crohn
Principal Investigator: Dr. med. Anja Schirbel
Patient (diseased)
Age: 18 - 80
Gender: All
Status: Participants wanted
Induktionsstudie 1 Multizentrische, randomisierte,doppelblinde, placebokontrollierte Phase-III-Studie zuoralem Ozanimod als Induktionstherapie desmittelschweren bis schweren aktiven Morbus Crohn
Short title: RPC01-3201
Investigated disease: Morbus Crohn
Principal Investigator: Dr. med. Anja Schirbel
Patient (diseased)
Age: 18 - 75
Gender: All
Status: Participants wanted
AUTOS-CHAGAS
Short title: AUTOS-CHAGAS
Investigated disease: Chagas-Krankheit
Principal Investigator: PD Dr. med. Thomas Zoller
Patient (diseased)
Status: Study in preparation
INTESTIREG
Short title: INTESTIREG-CED
Investigated disease: chronisch entzündliche Darmerkrankungen
Principal Investigator: Dr. med. Anja Schirbel
Patient (diseased)
Age: 18 - 80
Gender: All
Status: Participants wanted
A randomized, treatment open-label, dose-blinded parallel group, three arm, proof-of-concept clinical trial to investigate the efficacy and safety of LNP023 compared with rituximab in the treatment of subjects with idiopathic membranous nephropathy
Short title: LNP023 & membr. GN
Investigated disease: membranöse GN
Principal Investigator: PD Dr. Adrian Schreiber
Patient (diseased)
Age: 18 - 99
Gender: All
An adaptive seamless randomized, double-blind, placebo-controlled, dose ranging study to investigate the efficacy and safety of LNP023 in primary IgA nephropathy patients
Short title: LNP023 & IgANP
Investigated disease: Iga Nephropathy
Principal Investigator: PD Dr. Adrian Schreiber
Patient (diseased)
Age: 18 - 99
Gender: All
Status: Participants wanted